Skip to main content

Terra Innovatum and GSR III Acquisition Corp. Announce Shareholder Approval of Business Combination with $130 Million of Total Proceeds Expected at Close

$130 million in trust and equity financing proceeds to provide significant financial runway to complete first-of-a-kind SOLO™ micro-modular reactor licensing, production, and deployment Combination of capital-light business model and strong cash position at close expected to accelerate growth, commercial scale-up, and supply chain enhancements Ordinary shares expected to trade on Nasdaq under the symbol “NKLR”NEW YORK and AUSTIN, Texas, Oct. 07, 2025 (GLOBE NEWSWIRE) — Terra Innovatum Srl (“Terra Innovatum” or the “Company”), a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. (“GSRT“) (Nasdaq: GSRT), a publicly traded special purpose acquisition company, today announced that GSRT shareholders have voted to approve the previously announced business combination (“Business...

Continue reading

SPIE signs an agreement for the acquisition of ECOexperts Automation

Cergy, October 7th 2025 – SPIE, the independent European leader in multi-technical services in the areas of energy and communications, announces the agreement to acquire ECOexperts Automation GmbH (ECOexperts), based in Lebring (Styria, Austria). ECOexperts has established itself in recent years as a specialized systems integrator for tunnel and traffic management. The company provides engineering, project management and execution services. In 2024, ECOexperts generated revenues of €7 million. The company currently employs 21 people, mainly highly skilled engineers. Markus Holzke, Managing Director of SPIE Germany Switzerland Austria and Andreas Christandl, who leads the Austrian business at SPIE Germany Switzerland Austria, warmly welcome the ECOexperts team: “ECOexperts and SPIE know each other well. Our teams have been working together...

Continue reading

LBMC Physician Business Solutions Expands into Memphis with Addition of Shade Robinson and Physician Data Services Team

Strategic Partnership Strengthens LBMC’s Healthcare Revenue Cycle Management Capabilities and Deepens Presence in Memphis MarketShade Robinson joins LBMC Physician Business Solutions as Partner and Memphis Market Leader.LBMC Physician Business Solutions adds to leadership team and expands into Memphis through strategic partnership with Physician Data Services.NASHVILLE, Tenn., Oct. 07, 2025 (GLOBE NEWSWIRE) — LBMC Physician Business Solutions, LLC (PBS), a member of the LBMC Family of Companies, is pleased to announce its expansion into the Memphis market through a partnership with Memphis-based Physician Data Services (PDS). As part of this strategic growth transaction, Shade Robinson, founder of PDS, has joined PBS as Partner and Memphis Market Leader. Founded in 1991, PDS built a strong reputation over the past three...

Continue reading

NUBURU to Acquire Orbit, Expanding Defense & Security Hub with Cutting-Edge Operational Resilience Solutions

Acquisition Positions Nuburu Defense for Global Leadership in Defense-Grade SaaS Platforms Serving a $3.6 Billion Market Opportunity CENTENNIAL, Colo., Oct. 07, 2025 (GLOBE NEWSWIRE) — via IBN — NUBURU, Inc. (NYSE American: BURU) (“NUBURU” or the “Company”), a global pioneer in high-performance blue laser technology, today announced that its subsidiary, Nuburu Defense LLC, has secured a binding agreement (“Agreement”) to directly acquire 100% of Orbit S.r.l. (“Orbit”), an Italian software company specializing in operational resilience, business continuity, and crisis management for mission-critical organizations. The Agreement involves a two-phase transaction and marks a major step in the build-out of NUBURU’s Defense & Security Hub, expanding its capabilities beyond...

Continue reading

MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care

DANBURY, Conn. and BURLINGTON, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc. The acquisition of scPharmaceuticals is expected to diversify and accelerate MannKind’s double-digit revenue growth, driven by FUROSCIX® (furosemide injection)- an innovative therapy for edema due to chronic heart failure and chronic kidney disease. The transaction will strengthen MannKind’s commercial and medical capabilities by integrating scPharmaceuticals’ experienced team into its existing infrastructure. MannKind is positioned as a diversified, growth-focused biopharmaceutical company with its commercial assets—Afrezza®, FUROSCIX® and V-Go® — along with Tyvaso DPI®-related revenues, contributing to an annualized run rate of over...

Continue reading

Aptean Expands Dealer Management Platform and Nordic Footprint Through Acquisition of JMA

Cloud ERP solution purpose-built for agricultural and construction machinery industry RANDERS, Denmark and ALPHARETTA, Ga., Oct. 07, 2025 (GLOBE NEWSWIRE) — Aptean Inc., a global front-runner of AI-driven ERP solutions, is pleased to announce the acquisition of JMA A/S (“JMA”), a leading provider of dealer management system solutions for the heavy equipment, agricultural and construction machinery vertical in the Nordic market, headquartered in Randers, Denmark. The acquisition of JMA further increases Aptean’s Nordic footprint, while also bolstering the capabilities of Aptean’s dealer management offerings, purpose-built for the agricultural and construction machinery sector. Founded in 1990, JMA provides a mission-critical dealer management solution (“DSM”) which is designed to connect and digitize every part of the agricultural...

Continue reading

MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care

DANBURY, Conn. and BURLINGTON, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc. The acquisition of scPharmaceuticals is expected to diversify and accelerate MannKind’s double-digit revenue growth, driven by FUROSCIX® (furosemide injection), an innovative therapy for edema due to chronic heart failure and chronic kidney disease. The transaction will strengthen MannKind’s commercial and medical capabilities by integrating scPharmaceuticals’ experienced team into its existing infrastructure. MannKind is positioned as a diversified, growth-focused biopharmaceutical company with its commercial assets—Afrezza®, FUROSCIX® and V-Go®—along with Tyvaso DPI®-related revenues, contributing to an annualized run rate of over $370...

Continue reading

Barfresh Completes Strategic Acquisition of Arps Dairy

Transaction Positions Company for Accelerated Growth with Enhanced Manufacturing Capabilities and Operational Synergies Company on Track to Deliver Fiscal Year 2025 Revenue of $14.5 Million to $15.5 Million Acquisition Expected to More Than Double Revenue to $30 Million to $35 Million and Enhance Profitability in Fiscal Year 2026 LOS ANGELES, Oct. 07, 2025 (GLOBE NEWSWIRE) — Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, today announced that it has completed the previously announced acquisition of all outstanding capital stock of Arps Dairy, Inc., an Ohio-based dairy processing company. The transaction was completed primarily for approximately $1.3 million in debt repayment, funded through an expansion of the Company’s existing line of credit. The...

Continue reading

Bishop Street Underwriters Acquires Avid Insurance

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) — Bishop Street Underwriters (“Bishop Street”), a RedBird Capital Partners portfolio company, today announced that it has acquired Avid Insurance (“Avid”), a niche multi-disciplined managing general agent (“MGA”) based in London. This acquisition marks Bishop Street’s second strategic business expansion in the U.K. this year, further developing the capabilities of its platform with a deeper footprint in a core growth market. The transaction closed on October 3, 2025, with all requisite regulatory approvals. Financial terms were not disclosed. Founded in 2006, Avid delivers specialized insurance solutions for complex and underserved markets across sectors including construction, social housing and leasehold, with additional capabilities in equine, motor sport, gadget, student contents and...

Continue reading

Linamar Corporation to Acquire George Fischer’s Leipzig Facility

GUELPH, Ontario, Oct. 07, 2025 (GLOBE NEWSWIRE) — Linamar Corporation (TSX:LNR) is pleased to announce that it has entered into a definitive agreement to acquire 100% of the equity interest of George Fischer’s Leipzig Casting Facility. The transaction, valued at €45 million, diversifies Linamar’s casting solutions to include large ductile iron castings for Heavy Industrial On and Off-Highway applications. Leipzig is a technology leader in ductile iron castings with unique technical capabilities, including Europe’s largest molding box for machine-molded iron castings, providing solid growth opportunities for Linamar around highly complex cast components for a broad range of end markets.  The addition of the facility offers a significant amount of technology under one roof – from prototyping & 3D-printing to series...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.